Need all Congresses? Press Enter for expanded federal results.
HRES 95
114th Congress •
2015-2017 (Ended)
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.
Actions
Feb 6, 2015
Referred to the Subcommittee on Health.
Feb 5, 2015
Referred to the House Committee on Energy and Commerce.